FINWIRES · TerminalLIVE
FINWIRES

Ribomic Enrolls First Patient in Phase III Trials of Umedaptanib Pegol for Achondroplasia Treatment

By

Ribomic (TYO:4591) enrolled the first patient in the Phase III clinical trials of its umedaptanib pegol drug among pediatric patients with achondroplasia in Japan, according to a Thursday filing on the Tokyo Stock Exchange.

The Japan-based, clinical-stage biotechnology company said that the Phase III trials will enroll 16 patients aged between 2 and 14 years to evaluate the drug's efficacy and safety.

The single-arm study will involve once-weekly subcutaneous administration, with participants undergoing a mandatory 26-week observation period before dosing initiation.

Related Articles

Asia

SSY Gets China Production Nod for Methocarbamol Tablets, Registers Phloroglucinol Dihydrate

SSY Group (HKG:2005) obtained production and registration approval for Methocarbamol Tablets and registration approval for Phloroglucinol Dihydrate from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The approval for Methocarbamol Tablets came as the drug passed the regulator's consistency evaluation.Methocarbamol Tablets are muscle relaxants mainly used to treat joint and muscle sprains, lumbar muscle strain, and sciatica.Phloroglucinol Dihydrate is used to treat acute spasmodic pain associated with digestive, biliary, urinary, and gynecological conditions.Shares of the firm were up nearly 5% in late morning trade on Thursday.

HKG:2005
Asia

Bellavista Resources Starts Drilling at Canada, Western Australia Projects; Shares Gain 3%

Bellavista Resources (ASX:BVR) started drilling the Pickle Crow gold project in Canada and at its Brumby project in Western Australia, according to a Thursday filing with the Australian bourse.Initial drilling at Pickle Crow for the remainder of the year will assess the open-pit potential on the existing mineral resource of 2.7 million ounces at 7.2 grams per tonne grade of gold, before moving to additional near-surface regional targets in early 2027.At Brumby, the company will assess mineralization continuity for a potential future resource definition drilling program, alongside column leach test work.Bellavista Resources shares gained 3% in recent Thursday trade.

ASX:BVR
Asia

Binastra Unit Bags MYR491 Million Data Center Development Deal

Binastra (KLSE: BNASTRA) unit Binastra Builders secured a 491.2 million ringgit turnkey contract to develop a seven-story data center in Kuala Lumpur, according to a Wednesday Bursa Malaysia filing.The contract, awarded by Exsim Sri Permai, covers the design, construction, testing, commissioning, maintenance and guarantee works, including foundation, substructure, main building and infrastructure works.The project, which also includes a guardhouse, refuse room and electrical substation, is scheduled to begin on July 1 and be completed within 18 months.

KLSE:BNASTRA